Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Alejandro, Gugliucci"'
Autor:
Alejandro Gugliucci
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2024)
Since statins have had such tremendous therapeutic success over the last three decades, the field of atherosclerosis has become somewhat LDL-centric, dismissing the relevance of triglycerides (TG), particularly chylomicrons, in atherogenesis. Nonethe
Externí odkaz:
https://doaj.org/article/7ee352249f514c4ea455e8a6d5afeefd
Autor:
Ignacio Peralta, Carla Marrassini, Malen Saint Martin, Laura Cogoi, María Rosario Alonso, Alejandro Gugliucci, Claudia Anesini
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 22, Iss 1, Pp 1-16 (2022)
Abstract Background The oxidized low density lipoprotein (ox-LDL) contributes to inflammation and oxidative stress through the activation of macrophages under hyperglycemia contributing to the development of diabetes mellitus and to atherosclerosis.
Externí odkaz:
https://doaj.org/article/0d0517430940408c8a03bf3950c0c290
Autor:
Grace Marie Jones, Russell Caccavello, Sergiu P. Palii, Clive R. Pullinger, John P. Kane, Kathleen Mulligan, Alejandro Gugliucci, Jean-Marc Schwarz
Publikováno v:
Journal of Lipid Research, Vol 61, Iss 3, Pp 455-463 (2020)
Elevated levels of triglyceride-rich lipoproteins (TRLs), both fasting and postprandial, are associated with increased risk for atherosclerosis. However, guidelines for treatment are defined solely by fasting lipid levels, even though postprandial li
Externí odkaz:
https://doaj.org/article/9db46222ea3b45a89912dd109e562aee
Autor:
Ignacio Peralta, Carla Marrassini, Malen Saint Martin, Laura Cogoi, Maria Rosario Alonso, Alejandro Gugliucci, Claudia Anesini
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 22, Iss 1, Pp 1-2 (2022)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/64f01477c38849159248ce57555d5463
Publikováno v:
Revista Médica del Uruguay, Vol 36, Iss 4 (2020)
En esta revisión se resume el rol específico que el exceso de consumo de fructosa más allá de sus calorías puede tener en el desarrollo del síndrome metabólico, la esteatosis hepática no alcohólica y su asociación con la obesidad. Se desglo
Externí odkaz:
https://doaj.org/article/2d9e8483c23742f58da0415fe661672e
Publikováno v:
Antioxidants, Vol 10, Iss 12, p 1891 (2021)
Oxidative stress is a driving factor in the pathophysiology of chronic obstructive pulmonary disease (COPD). While paraoxonase 1 (PON1) is an antioxidant enzyme and a potential biomarker of this disease, data regarding the status of PON-1 in COPD are
Externí odkaz:
https://doaj.org/article/4275519deda548b68df58d632bf214f0
Publikováno v:
Methods. 203:5-9
Introduction Plasma D-lactate levels can be considered a surrogate indicator of MG flux. There are commercial methods specifically designed to cover pathological ranges (mmol/l in sepsis or leaky gut) that are not suitable to encompass the metabolica
Autor:
Reyna Rodríguez-Mortera, Russell Caccavello, Ricardo Hermo, María Eugenia Garay-Sevilla, Alejandro Gugliucci
Publikováno v:
Antioxidants, Vol 10, Iss 5, p 751 (2021)
Tightly regulated iron metabolism prevents oxidative stress. Hepcidin is a hormone that regulates iron flow in plasma; its production is induced by an iron overload and by inflammation. It inhibits iron entry into the circulation by blocking dietary
Externí odkaz:
https://doaj.org/article/9b1b2d0b1024465e9b60b169a62e67a2
Publikováno v:
Molecules, Vol 26, Iss 8, p 2323 (2021)
Oxidative stress is involved in the pathophysiology of nonalcoholic fatty liver disease (NAFLD). However, reliable biomarkers of NAFLD in relation to oxidative stress are not available. While paraoxonase 1 (PON1) is an antioxidant biomarker, there ap
Externí odkaz:
https://doaj.org/article/480a474cebdf48d49787f834200604b9
Autor:
Karla, Paola Gutiérrez Castro, Alma, Patricia González, Russell, Caccavello, Ma Eugenia, Garay-Sevilla, Alejandro, Gugliucci
Publikováno v:
Clinica Chimica Acta. 526:43-48
Triglyceride-rich lipoproteins (TRL: chylomicrons and VLDL) are a key component of diabetes dyslipoproteinemia and cardiovascular risk. We have shown that it is already prevalent in obese adolescents in association with lipoprotein lipase (LPL) dysre